Last Posted: Nov 08, 2019
- Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
Elsayegh Nisreen et al. Cancer medicine 2018 7(6) 2718-2726 - Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study.
Conley Claire C et al. Annals of surgical oncology 2019 Nov - Prospective Evaluation of a Breast Cancer Risk Model Integrating Classical Risk Factors and Polygenic Risk in 15 Cohorts from Six Countries
AN Wilcox et al., MedXRIV, November 5, 2019 - The ethical, legal and social implications of using artificial intelligence systems in breast cancer care.
Carter Stacy M et al. Breast (Edinburgh, Scotland) 2019 Oct 4925-32 - Genetic and Genomic Advances in Breast Cancer Diagnosis and Treatment.
Walker-Smith Tammy L et al. Nursing for women's health 2019 Oct - High Oncotype Recurrence Score, Hereditary Cancer Syndromes, and Referral for Genetic Testing.
Goel Arun Kumar et al. Clinical breast cancer 2019 Oct - Mutations and the Importance of Genetic Testing.
Kurian Allison W et al. Oncology (Williston Park, N.Y.) 2019 Oct 33(10) - The potential of ctDNA analysis in breast cancer.
Tzanikou Eleni et al. Critical reviews in clinical laboratory sciences 2019 Nov 1-19 - Year in Review: Ovarian Cancer: PARP inhibitors, genetic testing, and novel combinations
I Ingram, Medpage Today, November 1, 2019 - The BRCA gene is about so much more than breast cancer risk
A Goldman, Well and Good, October 27, 2019
.png)
No hay comentarios:
Publicar un comentario